Number of Hedge Fund Holders: 56 Illumina, Inc. (NASDAQ:ILMN) offers sequencing and array based solutions for genetic and ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

Though Illumina said goodbye to Grail this past ... of Grail could tempt it to wield its massive market share in DNA sequencing, and throttle back the research of its rivals in cancer screening.

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

Amid rising agricultural complexity and the push for sustainability, genomics is at the forefront of innovation in breeding ...

San Diego gene-sequencing pioneer Illumina on Tuesday won its court fight against the European Union’s investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail ...

Illumina, a leader in DNA sequencing and array-based technologies, is set to enhance the genomic sciences landscape in India by establishing a new Global Capability Center (GCC) in Bengaluru. This ...

San Diego-headquartered Illumina, a leader in DNA sequencing and array-based technologies, said it will establish a Global Capability Center (GCC) in Bengaluru as part of its plans to expand the ...

A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ ... fine that the U.S. gene sequencing company had to pay. However, the ruling ...

Illumina Inc. a global leader in DNA sequencing and array-based technologies, announced at the Illumina India Genomics Summit that it will establish a Global Capability Center in Bengaluru, India, as ...